13,575 Shares in Genpact Limited (NYSE:G) Purchased by Freedom Investment Management Inc.

Freedom Investment Management Inc. bought a new stake in Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 13,575 shares of the business services provider's stock, valued at approximately $583,000.

• Goldman Sachs Just Revealed What’s Next for Markets

Several other large investors have also recently bought and sold shares of the stock. SRH Advisors LLC acquired a new position in Genpact during the fourth quarter worth about $26,000. Atlas Capital Advisors Inc. grew its stake in shares of Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the last quarter. GeoWealth Management LLC raised its holdings in shares of Genpact by 199.0% in the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after purchasing an additional 583 shares in the last quarter. Manchester Capital Management LLC acquired a new stake in Genpact during the fourth quarter valued at approximately $38,000. Finally, Smartleaf Asset Management LLC boosted its holdings in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after buying an additional 783 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on G. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC boosted their target price on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Mizuho increased their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Finally, TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, Genpact currently has a consensus rating of "Hold" and an average target price of $48.44.

• Gold Rally Continues: These 3 Mining Stocks Are Likely to Benefit

Check Out Our Latest Report on Genpact

Insider Activity at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.80% of the company's stock.

Genpact Trading Down 0.4 %

• Greenbrier: Don’t Buy It For Revenue Growth—Buy It For Margin

NYSE:G opened at $47.56 on Monday. The stock has a market cap of $8.35 billion, a PE ratio of 16.75, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. Genpact Limited has a fifty-two week low of $30.38 and a fifty-two week high of $56.76. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock's 50-day moving average is $50.52 and its two-hundred day moving average is $46.13.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, equities research analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.43%. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. Genpact's dividend payout ratio (DPR) is currently 23.94%.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

• Five stocks we like better than Genpact
• Investing in the High PE Growth Stocks
• With a 60%+ Upside, There’s Plenty to Love About Lovesac
• What to Know About Investing in Penny Stocks
• J.B. Hunt Transport Overcorrects Into a Buying Opportunity
• Stock Splits, Do They Really Impact Investors?
• AppLovin: Can Record Profits Overcome Market Skepticism?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here